BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38818892)

  • 1. KNTC1 knockdown inhibits the proliferation and migration of osteosarcoma cells by MCM2.
    Zhong L; Dong Y; Liu S
    Mol Carcinog; 2024 May; ():. PubMed ID: 38818892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KNTC1 knockdown inhibits proliferation and metastases of liver cancer.
    Yang F; Yuan C
    3 Biotech; 2023 Sep; 13(9):309. PubMed ID: 37621322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KNTC1 and MCM2 are the molecular targets of gallbladder cancer.
    Jia W; Wang C
    Aging (Albany NY); 2023 Jul; 15(14):7008-7022. PubMed ID: 37480569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of KNTC1 Inhibits the Proliferation, Migration and Tumorigenesis of Human Bladder Cancer Cells and Induces Apoptosis.
    Huang H; Fan X; Qiao Y; Yang M; Ji Z
    Crit Rev Eukaryot Gene Expr; 2021; 31(1):49-60. PubMed ID: 33639055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. shRNA‑mediated knockdown of KNTC1 inhibits non-small-cell lung cancer through regulating PSMB8.
    Liu R; Liu R; Guo Z; Ren J; Huang J; Luo Q; Tan Q
    Cell Death Dis; 2022 Aug; 13(8):685. PubMed ID: 35933405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of KNTC1 in the regulation of proliferation, migration and tumorigenesis in colorectal cancer.
    Wang J; Ding Z; Shu W; Zhuge Y
    Cell Signal; 2023 Aug; 108():110728. PubMed ID: 37230198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minichromosome maintenance protein 2 and 3 promote osteosarcoma progression via DHX9 and predict poor patient prognosis.
    Cheng DD; Zhang HZ; Yuan JQ; Li SJ; Yang QC; Fan CY
    Oncotarget; 2017 Apr; 8(16):26380-26393. PubMed ID: 28460433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetochore-associated protein 1 promotes the invasion and tumorigenicity of cervical cancer cells via matrix metalloproteinase-2 and matrix metalloproteinase-9.
    Wang C; Wang Y; Liu C; Meng X; Hang Z
    Bioengineered; 2022 Apr; 13(4):9495-9507. PubMed ID: 35389773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
    Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SYT7 regulates the progression of chronic lymphocytic leukemia through interacting and regulating KNTC1.
    Zhang W; Long J; Tang P; Chen K; Guo G; Yu Z; Lin J; Liu L; Zhan R; Xu Z
    Biomark Res; 2023 Jun; 11(1):58. PubMed ID: 37280656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KNTC1 knockdown suppresses cell proliferation of colon cancer.
    Zhengxiang Z; Yunxiang T; Zhiping L; Zhimin Y
    3 Biotech; 2021 Jun; 11(6):262. PubMed ID: 33996374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
    Li G; Liu K; Du X
    Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis.
    Duan G; Zhang C; Xu C; Xu C; Zhang L; Zhang Y
    Int J Oncol; 2019 Jan; 54(1):17-28. PubMed ID: 30365098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of KNTC1 inhibits hepatocellular carcinoma cells progression via suppressing PI3K/Akt pathway.
    Tong H; Liu X; Peng C; Shen B; Zhu Z
    Cell Signal; 2023 Jan; 101():110498. PubMed ID: 36273753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. shRNA‑mediated knockdown of KNTC1 suppresses cell viability and induces apoptosis in esophageal squamous cell carcinoma.
    Liu CT; Min L; Wang YJ; Li P; Wu YD; Zhang ST
    Int J Oncol; 2019 Mar; 54(3):1053-1060. PubMed ID: 30628654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA HOTTIP facilitates cell proliferation, invasion, and migration in osteosarcoma by interaction with PTBP1 to promote KHSRP level.
    Yao XY; Liu JF; Luo Y; Xu XZ; Bu J
    Cell Cycle; 2021 Feb; 20(3):283-297. PubMed ID: 33475442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of DEPTOR inhibits the proliferation, migration, and survival of osteosarcoma through PI3K/Akt/mTOR pathway.
    Hu B; Lv X; Gao F; Chen S; Wang S; Qing X; Liu J; Wang B; Shao Z
    Onco Targets Ther; 2017; 10():4379-4391. PubMed ID: 28932123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KNTC1, regulated by HPV E7, inhibits cervical carcinogenesis partially through Smad2.
    Pan W; Wang S; Liu X; Wang M; Han X; Tian X; Lin J; Qiao X; Wang X
    Exp Cell Res; 2023 Feb; 423(1):113458. PubMed ID: 36608837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KNTC1 as a putative tumor oncogene in pancreatic cancer.
    Liu L; Chen H; Chen X; Yao C; Shen W; Jia C
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3023-3031. PubMed ID: 35852618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-129-5p suppresses cell proliferation, migration and invasion via targeting ROCK1 in osteosarcoma.
    Han C; Wang W
    Mol Med Rep; 2018 Mar; 17(3):4777-4784. PubMed ID: 29328417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.